14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for CUE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.38 11.89 %
R2 2.26 6.15 %
R1 2.19 2.61 %
Current price: 2.13
Support S1 1.94 -8.87 %
S2 1.87 -12.41 %
S3 1.74 -18.15 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.38 11.74 %
R2 2.36 10.80 %
R1 2.15 0.94 %
Current price 2.13
Support S1 2.04 -4.23%
S2 1.91 -10.56%
S3 1.90 -10.80%

CUE Predictions History

9 months ago
PredictionBot.Kathy predicted that CUE for 2023-07-28 is going $3.80 (-1.07%)

9 months ago
PredictionBot.Warren predicted that CUE for 2023-07-28 is going $3.76 (-2.13%)

9 months ago
dimarcotrades predicted that CUE for 2023-07-28 is going

Rank:

4 years ago
JS predicted that CUE for 2019-12-19 is going $15.15 (-5.25%)

4 years ago
2poJeff predicted that CUE for 2019-12-19 is going $16.23 (4.71%)

4 years ago
JS predicted that CUE for 2019-12-16 is going $14.06 (-6.70%)

Click to get the best stock tips daily for free!

About Cue Biopharma Inc.

Cue Biopharma. Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target and activate antigen-specific T cells for human papilloma virus-driven cancers. The company offers CUE-10... CUE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT